ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹783 Cr | ₹703 Cr | ₹645 Cr | ₹544 Cr | ₹448 Cr |
What is the latest Net Current Assets ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹783 Cr |
| Mar2024 | ₹703 Cr |
| Mar2023 | ₹645 Cr |
| Mar2022 | ₹544 Cr |
| Mar2021 | ₹448 Cr |
How is Net Current Assets of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹783 Cr | 11.34 | |
| Mar2024 | ₹703 Cr | 9.13 | |
| Mar2023 | ₹645 Cr | 18.48 | |
| Mar2022 | ₹544 Cr | 21.31 | |
| Mar2021 | ₹448 Cr | - | |
Compare Net Current Assets of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,524.6 Cr | -14.7% | -17.1% | -6.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,704.0 Cr | -0.5% | 3.9% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,684.0 Cr | -3.1% | -0.1% | 0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,093.0 Cr | 3.1% | 6.7% | 45.5% | Stock Analytics | |
| CIPLA | ₹117,699.0 Cr | 1.4% | 4.8% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,792.0 Cr | 0.8% | 3.9% | 1.5% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -14.7% |
-17.1% |
-6.2% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses